NCT00135837
- Conditions
- Age-Related Macular Degeneration, Choroid Diseases, Choroidal Neovascularization, +9 more
- Locations
-
- Novartis Basel, Switzerland
Clinical trial condition
Uveal Diseases
Explore clinical trials studying Uveal Diseases. Study availability and eligibility vary by location and protocol.
802 public trials
112 recruiting studies
Uveal Diseases trial results
NCT00305630
- Conditions
- Age-Related Macular Degeneration, Choroid Diseases, Choroidal Neovascularization, +9 more
- Locations
-
- Johns Hopkins Univeristy School of Medicine Baltimore, Maryland, United States
- Oregon Health Science Univeristy Portland, Oregon, United States
NCT00121147
- Conditions
- Exfoliation Syndrome, Eye Diseases, Glaucoma, +6 more
- Locations
-
- Doheny Eye Institute Los Angeles, California, United States
- The Eye Center Hamden, Connecticut, United States
- University of Florida Gainesville, Florida, United States
- Emory Healthcare Eye Center Atlanta, Georgia, United States
NCT00021736
- Conditions
- Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +8 more
- Locations
-
- Foundation for Fighting Blindness Baltimore, Maryland, United States
Active, Not Recruiting
Optimal Treatment Protocol for Selective Laser Trabeculoplasty
NCT03798223
- Conditions
- Exfoliation Syndrome, Eye Diseases, Glaucoma, +5 more
- Locations
-
- Ogonkliniken, Sodra Alvsborgs Sjukhus Borås, Västra Götaland County, Sweden
- Ogonkliniken, Sahlgrenska Universitetssjukhuset Mölndal, Västra Götaland County, Sweden
- Ogonkliniken, Skaraborgs Sjukhus Skövde, Västra Götaland County, Sweden
- Ogonkliniken NU-sjukvarden Uddevalla, Västra Götaland County, Sweden
Active, Not Recruiting
A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas
NCT05415072
- Conditions
- Eye Diseases, Eye Neoplasms, Melanoma, +15 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Columbia University Medical Center New York, United States
- Memorial Sloane Ketterin Cancer Ctr New York, United States
- Novartis Investigative Site Westmead, New South Wales, Australia
Active, Not Recruiting
Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With Pembrolizumab
NCT04130516
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +29 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
- Yale Cancer Center New Haven, Connecticut, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- University of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States
Active, Not Recruiting
A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers
NCT04328844
- Conditions
- Adenoma, Bone Marrow Diseases, Eye Diseases, +34 more
- Locations
-
- Humanitas Research Hospital Rozzano, Milan, Italy
- Medical Oncology and Immunotherapy Unit, University Hospital of Siena Siena, Italy
- Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
Active, Not Recruiting
C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)
NCT03635632
- Conditions
- Breast Diseases, Breast Neoplasms, Eye Diseases, +36 more
- Locations
-
- Houston Methodist Hospital Houston, Texas, United States
- Texas Children's Hospital Houston, Texas, United States
Active, Not Recruiting
Early Check: Expanded Screening in Newborns
NCT03655223
- Conditions
- 17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more
- Locations
-
- RTI International Research Triangle Park, North Carolina, United States